Tumor Characteristics and Clinical Features of the Patient as Prognostic Factors in PDAC
Cancers · 17.10.2025 · 17 (20) · 3350
DOI: 10.3390/cancers17203350 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 17.10.2025. Verfasst von Karina Udrycka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive Tract Disease, Medical University of Lodz, 90-647 Lodz, Poland. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz, Medical University of Lodz, Poland to Prof. Ewa Małecka-Wojciesko.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths among individuals over the age of 50. It is characterized by exceptional aggressiveness and is often diagnosed at an advanced stage, highlighting the importance of assessing prognostic factors. The deep awareness of these factors may help in better prevention and treatment planning, eventually improving the outcomes. Favorable prognostic factors include female gender, low tumor stage, ECOG (Eastern Cooperative Oncology Group) 0–1, lowest ASI (Activated Stroma Index), low-grade tumor budding, age below 40, adequate nutrition, and absence of distant metastases. Conversely, unfavorable prognostic factors include the presence of distant metastases and metastases into lymph nodes, high tumor stage, LVI (lymphovascular invasion), PNI (perineural invasion), tumor size above 3 cm, invasion into vessels, higher G grade, higher ASI, high-grade tumor budding, more than 1 CTC (circulating tumor cells) in the bloodstream, ECOG 3–4, age above 40, Black ethnicity, malnutrition, and sarcopenia. This review discusses the prognostic factors of PDAC related to tumor characteristics and the patient’s clinical issues. The aim of this review is to synthesize current evidence on prognostic determinants in PDAC, with particular attention to both tumor characteristics and patient-specific clinical features. To achieve this, a comprehensive literature review was performed using PubMed, BrowZine Library, Cochrane Library, SpringerLink, Wiley Online Library, BMJ Journals, and Google Scholar. Relevant studies addressing established and emerging prognostic markers were critically analyzed to provide an updated overview of factors that may influence survival and treatment outcomes. By integrating available data, this review seeks not only to summarize classical prognostic variables but also to highlight novel and underrecognized markers that may hold future clinical relevance. Such an approach may contribute to the refinement of prognostic models, support more accurate patient counseling, and ultimately aid in the optimization of therapeutic strategies for individuals affected by PDAC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Digestive Tract Disease, Medical University of Lodz, 90-647 Lodz, Poland.
ORCID-Profile: Karina Udrycka, Kamil Rutkowski, Anton Osnytskyy, Ewa Małecka-Wojciesko
Förderung
- Medical University of Lodz
- Medical University of Lodz, Poland to Prof. Ewa Małecka-Wojciesko
Zitieren
APA
Udrycka, K., Rutkowski, K., Osnytskyy, A., & Małecka-Wojciesko, E. (2025). Tumor Characteristics and Clinical Features of the Patient as Prognostic Factors in PDAC. Cancers, 17(20), 3350. https://doi.org/10.3390/cancers17203350
Vancouver
Udrycka K, Rutkowski K, Osnytskyy A, Małecka-Wojciesko E. Tumor Characteristics and Clinical Features of the Patient as Prognostic Factors in PDAC. Cancers. 2025;17(20):3350. doi:10.3390/cancers17203350
BibTeX
@article{Udrycka2025,
author = {Udrycka, Karina and Rutkowski, Kamil and Osnytskyy, Anton and Małecka-Wojciesko, Ewa},
title = {Tumor Characteristics and Clinical Features of the Patient as Prognostic Factors in PDAC},
journal = {Cancers},
year = {2025},
volume = {17},
number = {20},
pages = {3350},
doi = {10.3390/cancers17203350}
}
EUVIMED